| Net Cash Provided by (Used in) Operating Activities |
$247,761 |
USD |
-3986% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$6,063 |
USD |
-49% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
9,785,056 |
shares |
37% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$247,761 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$515,624 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,330,190 |
USD |
3.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$1,330,190 |
USD |
3.5% |
Q4 2024 |
FY 2024 |
| Depreciation |
$507 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,330,190 |
USD |
3.5% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$34,444,885 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
$5,138 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |